bioRxivGeneticsPreprint
Minimal phenotyping yields GWAS hits of reduced specificity for major depression
Na CaiiD, Joana A. ReveziD, Mark J. AdamsiD, Till F. M. AndlaueriD, Gerome D. BreeniD, Enda M. ByrneiD, Toni‐Kim ClarkeiD, Andreas J. ForstneriD, Hans Jörgen GrabeiD, Steven P. HamiltoniD, Douglas F. LevinsoniD, Cathryn M. LewisiD, Glyn LewisiD, Nicholas G. MartiniD, Yuri MilaneschiiD, Ole N MorsiD, Bertram Müller‐MyhsokiD, Brenda W.J.H. PenninxiD, Roy H. PerlisiD, Giorgio PistisiD, James B. PotashiD, Martin PreisigiD, Jianxin ShiiD, Jordan W. SmolleriD, Fabien StreitiD, , Jonathan Flint CiD
Abstract
Minimal phenotyping refers to the reliance on the use of a small number of self-report items for disease case identification. This strategy has been applied to genome-wide association studies (GWAS) of major depressive disorder (MDD). Here we report that the genotype derived heritability (h2SNP) of depression defined by minimal phenotyping (14%, SE = 0.8%) is lower than strictly defined MDD (26%, SE = 2.2%). This cannot be explained by differences in prevalence between definitions or including cases of lower liability to MDD in minimal phenotyping definitions of depression, but can be explained by misdiagnosis of those without depression or with related conditions as cases of depression. Depression defined by minimal phenotyping is as genetically correlated with strictly defined MDD (rG = 0.81, SE = 0.03) as it is with the personality trait neuroticism (rG = 0.84, SE = 0.05), a trait not defined by the cardinal symptoms of depression. While they both show similar shared genetic liability with neuroticism, a greater proportion of the genome contributes to the minimal phenotyping definitions of depression (80.2%, SE = 0.6%) than to strictly defined MDD (65.8%, SE = 0.6%). We find that GWAS loci identified in minimal phenotyping definitions of depression are not specific to MDD: they also predispose to other psychiatric conditions. Finally, while highly predictive polygenic risk scores can be generated from minimal phenotyping definitions of MDD, the predictive power can be explained entirely by the sample size used to generate the polygenic risk score, rather than specificity for MDD. Our results reveal that genetic analysis of minimal phenotyping definitions of depression identifies non-specific genetic factors shared between MDD and other psychiatric conditions. Reliance on results from minimal phenotyping for MDD may thus bias views of the genetic architecture of MDD and may impede our ability to identify pathways specific to MDD.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- research focus: fine-mapping
- research focus: polygenic risk
- approach: statistical model
- Citations
- 25
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Whats in a diagnosis? A genetic decomposition of major depression.
Bradley S. Jermy, Kylie P. Glanville, … Evangelos Vassos·Molecular PsychiatryPeer-reviewed·Jul 21, 2021
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
eQTLGen, Naomi R. Wray, … Niamh Mullins·Nature GeneticsPeer-reviewed·Apr 26, 2018
- Investigating Genetic Heterogeneity in Major Depression Through Item-level Genetic Analyses of the PHQ-9
Jackson G. Thorp, Andries T. Marees, … Eske M. Derks·Psychological MedicinePeer-reviewed·Sep 18, 2019
- Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities
Thomas D. Als, Mitja Kurki, … Anders Dupont Børglum·Nature MedicinePeer-reviewed·Jul 1, 2023
- Genetic structure of major depression symptoms across clinical and community cohorts
Mark J. Adams, Jackson G. Thorp, … Eske M. Derks·medRxiv·Jul 5, 2023
- Genome-wide association study of depression phenotypes in UK Biobank (n = 322,580) identifies the enrichment of variants in excitatory synaptic pathways
David M. Howard, Mark J. Adams, … Andrew Mark McIntosh·Nature CommunicationsPeer-reviewed·Apr 11, 2018